Concepedia

Tatiana Zavorotinskaya

TZ

15

Publications

739

Citations

14

H-Index

1996

Active since

Affiliations

University of Tennessee Health Science Center(Current)

Novartis (Switzerland)

Novartis Institutes for BioMedical Research

Novartis (United States)

Tatiana Zavorotinskaya is an author at University of Tennessee Health Science Center specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1996–2020

15

Publications

15

Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation

Jing Lü, Tatiana Zavorotinskaya, Yumin Dai et al. · Blood · 2013 · 161 citations · Full text

Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers

Pablo D. García, John L. Langowski, Yingyun Wang et al. · Clinical Cancer Research · 2014 · 110 citations · Full text

Identification of <i>N</i>-(4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies

Matthew T. Burger, Gisele Nishiguchi, Wooseok Han et al. · Journal of Medicinal Chemistry · 2015 · 72 citations · Full text

, , +14

Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors

Matthew T. Burger, Wooseok Han, Jiong Lan et al. · ACS Medicinal Chemistry Letters · 2013 · 52 citations · Full text

, , +19

Suppression of a Fusion Defect by Second Site Mutations in the Ecotropic Murine Leukemia Virus Surface Protein

Tatiana Zavorotinskaya, Lorraine M. Albritton · Journal of Virology · 1999 · 48 citations · Full text

Rows per page

1–5 of 15